Ke Ren, Ph.D.

US Food and Drug Administration

Poster(s):

• (W0930-10-63) Alternative Approach to Demonstrate Bioequivalence of Generic Formulations of Sucralfate Oral Suspension
  Wednesday, October 25, 2023

  9:30 AM – 10:30 AM ET

• (M1430-12-83) Common Deficiencies Using Alternative Bioequivalence Approach for Metered Dose Inhaler in Abbreviated New Drug Applications
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET

• (T1230-10-64) Scientific and Regulatory Considerations of Applying Morphologically Directed Raman Spectroscopy in Bioequivalence Assessment for Generic Orally Inhaled and Nasal Drug Products
  Tuesday, October 24, 2023

  12:30 PM – 1:30 PM ET